Circular RNA Therapeutics: Engineering Stability and Programmability in RNA Medicine
Circular RNA (circRNA) therapeutics are rapidly emerging as a next-generation platform in RNA medicine. Unlike conventional linear mRNA, circRNAs form covalently closed loops, which confer resistance to exonucleases, enhanced stability, and prolonged protein expression in cells. By exploiting these features, researchers are developing circRNA-based vaccines, protein replacement therapies, and cell engineering tools. For attorneys, circRNA…
Synthetic RNA Therapeutics: Engineering the Transcriptome for Precision Medicine
RNA-based therapeutics have rapidly emerged as a transformative class of medicines, exemplified by mRNA vaccines, small interfering RNA (siRNA), antisense oligonucleotides (ASOs), and CRISPR guide RNAs. Unlike DNA-based therapies, RNA therapeutics operate directly at the transcriptome level, enabling transient and programmable modulation of gene expression. This capacity positions RNA as both a therapeutic modality and…
Double Stranded Oligonucleotide Compositions for RNA Interference and Methods Relating Thereto
Patent Title: Double Stranded Oligonucleotide Compositions for RNA Interference and Methods Relating TheretoPublication Number: US 20250382617 A1Filing Date: August 29, 2025Publication Date: December 18, 2025Applicant/Assignee: Wave Life Sciences Ltd. What This Covers This patent application focuses on novel double‑stranded oligonucleotide molecules and associated compositions designed to mediate RNA interference (RNAi) — a mechanism by which specific gene expression is silenced in…
BioTech IP Review 